- The pancreatic cancer treatment market has witnessed considerable growth over the past. It is also likely to grow at around 25.3 percent CAGR by the end of 2017. This is due to rising aged population, developments in technology and government expenditures on cancer treatment.
For Market Research Report on “Pancreatic Cancer Treatment Market” Visit – http://www.grandviewresearch.com/industry-analysis/pancreatic-cancer-treatment-market
The United States has the largest number of pancreatic patients globally. Pancreatic cancer is common in men and women between ages of more than 60. Changing lifestyles, obesity, smoking, alcohol consumption and old age are the factors which propel further demand for the pancreatic cancer treatment market. Pancreatic cancer treatments often give insufficient results and may serve as a barrier for the market.
Pancreatic cancer patients are generally diagnosed at an advanced stage. Thus pancreatic cancer treatment market technology for timely diagnosis needs to be developed. Pancreatic cancer has five stages, out of which stage 1 and stage 2 can be cured surgically. Some of the common imaging methods are MRI, ultrasound and CT scan. ERCP (Endoscopic retrograde cholangiopancreatography) is an advanced procedure for diagnosing pancreatic cancer.
The pancreatic cancer treatment market can be segmented on account of whether the cancer affects exocrine or endocrine functions. Adenocarcinoma is the most common exocrine pancreatic cancer. Adenosquamous carcinoma, giant cell carcinoma and squamous cell carcinoma are the other types of endocrine pancreatic cancers.
The United States has shown huge growth for the pancreatic cancer treatment market. It is likely to register USD 1.18 billion by the end of 2017. It would be followed by five European nations. These nations are estimated to have a collective market worth around USD 463 million by 2017. This is due to rising aged population and changing lifestyles in these regions.
Information Source: Grand View Research
To request a sample copy of this report, please complete the form below.
To purchase a copy of this report, please contact at
28 2nd Street, Suite 3036
San Francisco, CA 94105
Toll Free: 1-888-202-9519